Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review

Article ID	Journal	Published Year	Pages	File Type
8227319	International Journal of Radiation OncologyBiologyPhysics	2012	8 Pages	PDF

Abstract

SBRT and surgery differ in risk of 30-day mortality in patients with severe COPD. Despite the negative selection of SBRT patients, survival at 1 and 3 years is comparable between the two treatments.

Keywords

Chronic obstructive pulmonary disease Non–small-cell lung cancer Surgery stereotactic body radiation therapy

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review

Authors

David M.D., M.Sc., F.R.C.P.C., Frank M.D., Ph.D., George M.D., M.Sc., F.R.C.P.C., Cornelis M.D., Ph.D., Suresh M.R.C.P., F.R.C.R., Ph.D.,